SENP2 and Hepatic fibrosis: Finally, the expression of the Wnt/β-catenin pathway members was downregulated upon SENP2 overexpression in TGF-β-activated HSCs, thus suggesting a therapeutic role of SENP2 in liver fibrosis [79].